Compare NBIX & RS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBIX | RS |
|---|---|---|
| Founded | 1992 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 14.9B |
| IPO Year | 1996 | 1994 |
| Metric | NBIX | RS |
|---|---|---|
| Price | $137.43 | $330.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 4 |
| Target Price | $176.24 | ★ $317.25 |
| AVG Volume (30 Days) | ★ 1.1M | 288.9K |
| Earning Date | 02-11-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 1.47% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | 4.19 | ★ 13.63 |
| Revenue | $2,682,700,000.00 | ★ $13,922,300,000.00 |
| Revenue This Year | $23.55 | $6.03 |
| Revenue Next Year | $19.18 | $4.86 |
| P/E Ratio | $32.13 | ★ $23.91 |
| Revenue Growth | ★ 19.61 | N/A |
| 52 Week Low | $84.23 | $250.07 |
| 52 Week High | $160.18 | $347.44 |
| Indicator | NBIX | RS |
|---|---|---|
| Relative Strength Index (RSI) | 48.52 | 74.75 |
| Support Level | $132.75 | $320.50 |
| Resistance Level | $138.74 | $336.55 |
| Average True Range (ATR) | 3.36 | 6.67 |
| MACD | 0.55 | 0.43 |
| Stochastic Oscillator | 86.35 | 81.70 |
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Reliance Inc is a diversified metal solutions provider and metals service center company. It provides value-added metals processing services and distributes.